Literature DB >> 1318377

Characterization of the sodium channel blocking properties of the major metabolites of cocaine in single cardiac myocytes.

W J Crumb1, C W Clarkson.   

Abstract

Clinical reports indicate that almost 30% of cocaine overdose-related deaths occur 2 to 5 hr after administration, when an appreciable amount of cocaine can be expected to have been converted to metabolites. We investigated the effects of the three major metabolites of cocaine: benzoylecgonine, ecgonine methyl ester and norcocaine on sodium channels in isolated guinea pig myocytes using the whole cell variant of the patch clamp technique at 16 +/- 0.5 degrees C. Benzoylecgonine and ecgonine methyl ester did not produce a significant block of sodium current at a concentration of 100 microM. In contrast, 30 microM norcocaine was found to reduce sodium current in a use-dependent manner qualitatively similar to cocaine. The time course of sodium current block development and recovery were characterized. With 30 microM norcocaine, two phases of block development were defined: a rapid phase (tau = 11.9 +/- 11.6 msec) and a slow phase (tau = 2.2 +/- 0.5 sec). Recovery from drug-induced block at -140 mV was approximately twice as fast for norcocaine (tau = 4.6 +/- 1.7 sec, n = 7) compared to cocaine (tau = 8.4 +/- 0.9 sec, n = 6). Norcocaine was found to have a higher affinity for inactivated cardiac sodium channels (Kdi = 5.7 +/- 0.9 microM) than cocaine (Kdi = 7.8 +/- 1.2 microM) (P less than .01); however, norcocaine produced less use-dependent block due to its faster unbinding kinetics. These data indicate that although norcocaine and cocaine are potent sodium channel blockers, benzoylecgonine and ecgonine methyl ester are ineffective blockers at clinically relevant concentrations (i.e., less than or equal to 100 microM).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318377

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity.

Authors:  S N Wright; S Y Wang; R G Kallen; G K Wang
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

2.  The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Remy L Brim; Kathleen R Noon; Gregory T Collins; Joseph Nichols; Diwahar Narasimhan; Roger K Sunahara; James H Woods
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

3.  Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.

Authors:  Natalie E Zlebnik; Stephen Brimijoin; Yang Gao; Amy T Saykao; Robin J Parks; Marilyn E Carroll
Journal:  Neuropsychopharmacology       Date:  2014-01-10       Impact factor: 7.853

4.  A quantitative LC-MS/MS method for simultaneous determination of cocaine and its metabolites in whole blood.

Authors:  Xiabin Chen; Xirong Zheng; Kai Ding; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  J Pharm Biomed Anal       Date:  2016-11-11       Impact factor: 3.935

Review 5.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

6.  Monoamine uptake inhibitors alter cocaine pharmacokinetics.

Authors:  S R Tella; S R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Delayed resolution of pulmonary oedema after cocaine/heroin abuse.

Authors:  P G Raijmakers; A B Groeneveld; M C de Groot; G J Teule; L G Thijs
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

8.  Preoperative screening and case cancellation in cocaine-abusing veterans scheduled for elective surgery.

Authors:  Nabil Elkassabany; Rebecca M Speck; David Oslin; Mary Hawn; Khan Chaichana; John Sum-Ping; Jorge Sepulveda; Mary Whitley; Yasser Sakawi
Journal:  Anesthesiol Res Pract       Date:  2013-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.